<DOC>
	<DOCNO>NCT01828593</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness oral nutritional therapy serum-derived bovine immunoglobulin protein isolate ( SBI ) 2.5 g twice day ( BID ) SBI 5.0 g versus placebo support nutrient absorption HIV+ subject HIV-associated enteropathy .</brief_summary>
	<brief_title>Impact SBI , Medical Food , Nutritional Status Patients With HIV-associated Enteropathy</brief_title>
	<detailed_description>This study evaluate effectiveness oral nutritional therapy serum-derived bovine immunoglobulin protein isolate ( SBI ) 2.5g BID SBI 5.0g compare placebo 6 month gastrointestinal symptom , nutritional status quality life HIV+ subject HIV-associated enteropathy . In addition , effect SBI pro-inflammatory intestinal microbial population , bacterial translocation , intestinal barrier function , systemic immune activation investigate .</detailed_description>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>HIV Enteropathy</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>History HIV1 infection Plasma HIV viral load â‰¤40 copies/mL Maintained virologic suppression 1 year Stable Antiretroviral Therapy ( ART ) regimen History HIVassociated diarrhea define abnormal passage 3 unformed stool per day liquid stool volume great 200 g per day least 4 week duration Positive stool test pathogenic bacteria , C. difficile ovum parasites Conditions require chronic therapy know alter gut microbiota Antibiotics within 2 week screen ( exception : prophylaxis antibiotic )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>